Biopharmaceutical Stocks

Shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical company that focuses on therapeutics that target post-transcriptional control processes, surged higher by more than 40 percent Friday afternoon. Investors and traders were reacting to the company's announcement that the...

Shares of AbbVie Inc (NYSE: ABBV) were trading lower by more than 4 percent early Friday morning after the company reported its fourth quarter results. AbbVie earned $1.13 per share in the fourth quarter on revenue of $6.36 billion. Wall Street analysts were expecting the company to earn $1.12...

Shares of Fate Therapeutics Inc (NASDAQ: FATE), a clinical-stage biopharmaceutical company engaged in the development of programmed cellular therapeutics, were trading lower by 5 percent at $2.37. Fate Therapeutics' stock was trading higher by more than 16 percent in the pre-market trading session...

Shares of AEterna Zentaris Inc. (NASDAQ: AEZS), a specialty nano-cap bio-pharmaceutical company engaged in developing treatments in oncology, endocrinology and women's health, surged higher by more than 17 percent on Monday after the company confirmed that several of its executive managers...